Vivos Therapeutics (VVOS) Interest Expenses (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Interest Expenses of -$1.4 million for Q1 2026, down 4848.28% year-over-year from $29000.0 in Q1 2025, and down 272.12% quarter-over-quarter from $800000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Interest Expenses (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Interest Expenses for 8 consecutive years, with -$1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses fell 4848.28% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$1.4 million (down 4848.28% YoY), while the FY2025 annual figure was -$2.0 million, down 109.36% from the prior year.
- Interest Expenses retreated to -$1.4 million in Q1 2026 per VVOS's latest filing, from $800000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $2.7 million in Q2 2023 and bottomed at -$1.4 million in Q1 2026.
- Historically, Interest Expenses has averaged $578750.0 across 5 years, with a median of $493500.0 in 2023.
- Annual changes were most pronounced in 2022 — Interest Expenses surged 10800.0% — and 2026, when it tumbled 4848.28%.
- Vivos Therapeutics' Interest Expenses stood at $436000.0 in 2022, then soared by 475.0% to $2.5 million in 2023, then sank by 75.83% to $606000.0 in 2024, then surged by 32.01% to $800000.0 in 2025, then plunged by 272.12% to -$1.4 million in 2026.
- Business Quant data shows VVOS's Interest Expenses at -$1.4 million in Q1 2026, $800000.0 in Q4 2025, and -$338000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 141.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 176.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 96.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 114.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -110.42 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Vivos Therapeutics | 4.81 Mn | 3.01 Mn | 2.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.38 Mn |
| Mar 31, 2026 | -1.38 Mn |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | -338,000.00 |
| Sep 30, 2025 | -338,000.00 |
| Jun 30, 2025 | -725,000.00 |
| Jun 30, 2025 | -725,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | 606,000.00 |
| Dec 31, 2024 | 606,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 493,000.00 |
| Jun 30, 2024 | 493,000.00 |
| Mar 31, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Sep 30, 2023 | 2.51 Mn |
| Sep 30, 2023 | 2.51 Mn |